Résultats de recherche
Issue Highlights. ATRA resistance in atypical APL explained. iTTP management without plasma exchange. Inflammasomes in Kaposi sarcoma herpesvirus–associated diseases. KDM6A controls immunogenicity in myeloma. RBCs enhance platelet reactivity and hemostasis. Pregnancy after allo-HCT.
About Blood — For specific information detailing Blood’s scope. Article Types — For detailed descriptions of the various article types that will be considered for publication by Blood. Editorial Policies — For detailed descriptions of Blood Journal Portfolio policies.
11 mai 2023 · Charles R. M. Bangham reviews the basis for viral persistence and the molecular events of driver mutation acquisition and immune evasion that lead to the emergence of ATL. View Article.
4 janv. 2024 · Browse covers. Browse by volume. Volume 143, Issue 1 January 4 2024 Pages 1-93 Cover image. Volume 143, Issue 2 January 11 2024 Pages 95-184 Cover image. Volume 143, Issue 3 January 18 2024 Pages 185-291 Cover image. Volume 143, Issue 4 January 25 2024 Pages 293-377 Cover image. Volume 143, Issue 5 February 1 2024 Pages 379-474 Cover image.
Journal Facts. Frequency of publication: Weekly, 52 issues annually, published every Thursday, except for the last week of the year, plus Annual Meeting Abstracts in mid-November; two volumes per year (2018: volumes 131 & 132).
4 mai 2023 · In this Perspective, Mohamed L. Sorror reviews the currently available disease-related and nonrelapse mortality indices, identifying their strengths and weaknesses while providing practical recommendations for current decision-making in HSCT and future refinements to prognostic modeling. View Article.
Advertising in Blood. Terms and Conditions. Twitter. American Society of Hematology. 2021 L Street NW, Suite 900. Washington, DC 20036. TEL +1 202-776-0544. FAX +1 202-776-0545. ASH Publications.
23 nov. 2021 · Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study. Pyridoxine: beyond a cofactor of ALAS. T-ALL and T-LBL: a notch apart. CARdinal signs of variant ICANS.
Single-case reports or small case series are considered in the journal only if they offer truly important data elucidating disease biology or therapy. Letters to Blood include no more than 1,200 words of text, 25 references, and 2 figures or tables. Letters must include a focused abstract of no more than 40 words.
Organize the content of your manuscript file as follows: Title Page, Key Points, Abstract, Introduction, Methods, Results, Discussion, Acknowledgments, Authorship Contributions, Conflict of Interest Disclosures, References, Tables, Figure Legends, and Figures. For Brief Reports, Results and Discussion must be combined.
